(VIANEWS) – Jiayin Group (JFIN), Provident Financial Services (PFS), Harmony Biosciences Holdings (HRMY) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Jiayin Group (JFIN)
141.3% sales growth and 186.27% return on equity
Jiayin Group Inc. operates as an online individual finance platform that connects individual investors and individual borrowers in China. It operates a secure and open platform that facilitates transparent, secure, and fast connections between investors and borrowers. The company was founded in 2011 and is based in Shanghai, the People's Republic of China.
Earnings Per Share
As for profitability, Jiayin Group has a trailing twelve months EPS of $3.4.
PE Ratio
Jiayin Group has a trailing twelve months price to earnings ratio of 1.68. Meaning, the purchaser of the share is investing $1.68 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 186.27%.
2. Provident Financial Services (PFS)
82.7% sales growth and 10.56% return on equity
Provident Financial Services, Inc. operates as the holding company for Provident Bank that provides various banking services to individuals, families, and businesses in the United States. The company's deposit products include savings, checking, interest-bearing checking, money market deposit, and certificate of deposit accounts, as well as IRA products. Its loan portfolio comprises commercial real estate loans that are secured by properties, such as multi-family apartment buildings, office buildings, and retail and industrial properties; commercial business loans; fixed-rate and adjustable-rate mortgage loans collateralized by one- to four-family residential real estate properties; commercial construction loans; and consumer loans consisting of home equity loans, home equity lines of credit, marine loans, personal loans, and auto and recreational vehicle loans. The company also offers cash management, remote deposit capture, payroll origination, escrow account management, and online and mobile banking services; and business credit cards. In addition, it provides wealth management services comprising investment management, trust and estate administration, financial planning, tax compliance and planning, and private banking. Further, the company sells insurance and investment products, including annuities; operates as a real estate investment trust for acquiring mortgage loans and other real estate related assets; and manages and sells real estate properties acquired through foreclosure. As of December 31, 2019, it operated 83 full-service branch offices in northern and central New Jersey, as well as in Pennsylvania. The company was founded in 1839 and is headquartered in Jersey City, New Jersey.
Earnings Per Share
As for profitability, Provident Financial Services has a trailing twelve months EPS of $2.31.
PE Ratio
Provident Financial Services has a trailing twelve months price to earnings ratio of 7.01. Meaning, the purchaser of the share is investing $7.01 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.56%.
3. Harmony Biosciences Holdings (HRMY)
33.3% sales growth and 57.63% return on equity
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy in the United States. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.
Earnings Per Share
As for profitability, Harmony Biosciences Holdings has a trailing twelve months EPS of $3.12.
PE Ratio
Harmony Biosciences Holdings has a trailing twelve months price to earnings ratio of 11.58. Meaning, the purchaser of the share is investing $11.58 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 57.63%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 64.1% and a drop 52.8% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 39.6%, now sitting on 471.67M for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Harmony Biosciences Holdings’s EBITDA is 3.98.
Sales Growth
Harmony Biosciences Holdings’s sales growth is 33.6% for the current quarter and 33.3% for the next.
4. Discover Financial Services (DFS)
17.4% sales growth and 29.74% return on equity
Discover Financial Services, through its subsidiaries, provides digital banking products and services, and payment services in the United States. It operates in two segments, Digital Banking and Payment Services. The Digital Banking segment offers Discover-branded credit cards to individuals; private student loans, personal loans, home loans, and other consumer lending; and direct-to-consumer deposit products comprising savings accounts, certificates of deposit, money market accounts, IRA certificates of deposit, IRA savings accounts and checking accounts, and sweep accounts. The Payment Services segment operates the PULSE, an automated teller machine, debit, and electronic funds transfer network; and Diners Club International, a payments network that issues Diners Club branded charge cards and/or provides card acceptance services, as well as offers payment transaction processing and settlement services. The company was incorporated in 1960 and is based in Riverwoods, Illinois.
Earnings Per Share
As for profitability, Discover Financial Services has a trailing twelve months EPS of $14.86.
PE Ratio
Discover Financial Services has a trailing twelve months price to earnings ratio of 6.89. Meaning, the purchaser of the share is investing $6.89 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.74%.
Sales Growth
Discover Financial Services’s sales growth is 20.2% for the current quarter and 17.4% for the next.
Moving Average
Discover Financial Services’s worth is above its 50-day moving average of $99.68 and under its 200-day moving average of $102.61.
Revenue Growth
Year-on-year quarterly revenue growth declined by 3.5%, now sitting on 10.88B for the twelve trailing months.
Volume
Today’s last reported volume for Discover Financial Services is 1786080 which is 15.37% below its average volume of 2110660.
5. Medpace Holdings (MEDP)
16.8% sales growth and 53.97% return on equity
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also provides clinical development services to the biotechnology, pharmaceutical, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. The company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Earnings Per Share
As for profitability, Medpace Holdings has a trailing twelve months EPS of $7.81.
PE Ratio
Medpace Holdings has a trailing twelve months price to earnings ratio of 27. Meaning, the purchaser of the share is investing $27 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 53.97%.
Yearly Top and Bottom Value
Medpace Holdings’s stock is valued at $210.88 at 11:22 EST, way under its 52-week high of $241.48 and way higher than its 52-week low of $129.65.
6. Tesla (TSLA)
15.9% sales growth and 27.99% return on equity
Tesla, Inc. designs, develops, manufactures, leases, and sells electric vehicles, and energy generation and storage systems in the United States, China, and internationally. It operates in two segments, Automotive, and Energy Generation and Storage. The Automotive segment offers electric vehicles, as well as sells automotive regulatory credits; and non-warranty after-sales vehicle, used vehicles, retail merchandise, and vehicle insurance services. This segment also provides sedans and sport utility vehicles through direct and used vehicle sales, a network of Tesla Superchargers, and in-app upgrades; purchase financing and leasing services; services for electric vehicles through its company-owned service locations and Tesla mobile service technicians; and vehicle limited warranties and extended service plans. The Energy Generation and Storage segment engages in the design, manufacture, installation, sale, and leasing of solar energy generation and energy storage products, and related services to residential, commercial, and industrial customers and utilities through its website, stores, and galleries, as well as through a network of channel partners; and provision of service and repairs to its energy product customers, including under warranty, as well as various financing options to its solar customers. The company was formerly known as Tesla Motors, Inc. and changed its name to Tesla, Inc. in February 2017. Tesla, Inc. was incorporated in 2003 and is headquartered in Austin, Texas.
Earnings Per Share
As for profitability, Tesla has a trailing twelve months EPS of $3.55.
PE Ratio
Tesla has a trailing twelve months price to earnings ratio of 54.41. Meaning, the purchaser of the share is investing $54.41 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.99%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 24.4%, now sitting on 86.03B for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Tesla’s EBITDA is 5.71.
Volume
Today’s last reported volume for Tesla is 162062000 which is 22.25% above its average volume of 132564000.
Moving Average
Tesla’s value is above its 50-day moving average of $178.74 and under its 200-day moving average of $200.22.
Previous days news about Tesla(TSLA)
- Ford stock news and forecast: new agreement will give customers access to 12,000 Tesla chargers. According to FXStreet on Friday, 26 May, "The idea is that we don’t want the Tesla supercharger network to be like a walled garden," Musk told the Twitter Spaces audience of more than 18,000. ", "The announcement was made via a Twitter Spaces talk between Tesla (TSLA) CEO Elon Musk and Farley late Thursday."
- Ford (f) to add Tesla chargers to its electric lineup. According to Zacks on Friday, 26 May, "Ford’s existing owners will be able to charge their electric vehicles at Tesla Superchargers using an adapter, whereas its next-generation EV owners will not need an adapter to charge their vehicles at Superchargers.", "Ford Motor Company (F Quick QuoteF – Free Report) announces a deal to add Tesla (TSLA Quick QuoteTSLA – Free Report) plugs to its current and future electric vehicles. "
- Electrifying opportunities in EV etfs as Tesla & ford join forces. According to Zacks on Friday, 26 May, "With an impressive fleet of 17,711 Superchargers, Tesla dominates nearly 60% of the U.S. fast-charging market. ", "Starting in 2025, Ford will incorporate Tesla’s charging standard into its EVs, eliminating the need for an adapter and providing direct access to Tesla Superchargers. "
7. Ambev (ABEV)
11.2% sales growth and 18.22% return on equity
Ambev S.A., through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, other non-alcoholic beverages, malt, and food products. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe and Hoegaarden, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands. The company also provides carbonated soft drinks, bottled water, isotonic beverages, energy drinks, coconut water, powdered and natural juices, and ready-to-drink teas under the Guaraná Antarctica, Gatorade, H2OH!, Lipton Iced Tea, Fusion, Do Bem, Pepsi-Cola, Canada Dry, Squirt, Red Rock, Red Bull, Seven Up, Nutrl, Bud Light Seltzer, Palm Bay, and Mike's brands. It offers its products through a network of third-party distributors and a direct distribution system. The company was founded in 1885 and is headquartered in São Paulo, Brazil. Ambev S.A. operates as a subsidiary of Interbrew International B.V.
Earnings Per Share
As for profitability, Ambev has a trailing twelve months EPS of $0.19.
PE Ratio
Ambev has a trailing twelve months price to earnings ratio of 15.39. Meaning, the purchaser of the share is investing $15.39 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.22%.
8. ITT Corporation (ITT)
7.9% sales growth and 18.01% return on equity
ITT Inc. manufactures and sells engineered critical components and customized technology solutions for the energy, transportation, and industrial markets worldwide. The company operates through three segments: Motion Technologies, Industrial Process, and Connect & Control Technologies. The Motion Technologies segment manufactures brake pads, shims, shock absorbers, and energy absorption components; and sealing technologies primarily for the transportation industry, including passenger cars, light- and heavy-duty commercial and military vehicles, buses, and rail. The Industrial Process segment designs and manufactures industrial pumps, valves, and plant optimization systems; and centrifugal process pumps, twin screw, axials, and positive displacement pumps, and water systems, as well as aftermarket solutions, such as repairs and upgrades services. It serves various customers in industries, such as chemical, oil and gas, mining, and other industrial process markets. The Connect & Control Technologies segment designs and manufactures a range of engineered connectors and specialized control components for critical applications supporting various markets, including aerospace and defense, industrial, transportation, medical, and oil and gas. The connector product portfolio includes electrical connectors, such as circular, rectangular, radio frequency, fiber optic, D-sub miniature, micro-miniature, and cable assemblies; and control products consist of fuel and water pumps, valves, electro-mechanical rotary and linear actuators, and pressure, temperature, limit, and flow switches for various aircraft systems. ITT Inc. was founded in 1920 and is headquartered in White Plains, New York.
Earnings Per Share
As for profitability, ITT Corporation has a trailing twelve months EPS of $4.72.
PE Ratio
ITT Corporation has a trailing twelve months price to earnings ratio of 17.4. Meaning, the purchaser of the share is investing $17.4 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.01%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
ITT Corporation’s EBITDA is 2.27.
Sales Growth
ITT Corporation’s sales growth is 7.8% for the present quarter and 7.9% for the next.
Moving Average
ITT Corporation’s value is under its 50-day moving average of $82.93 and above its 200-day moving average of $81.07.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.9%, now sitting on 3.06B for the twelve trailing months.
